BLAU

Blau Farmacêutica S.A

BLAU3 • SA

R$8.98-R$0.32 (3.44%)

Estimate

P/E

9.6

EPS

0.94

Beta

0.392

Growth

Revenue, YoY

16.61%

Net income, YoY

-56.27%

FCF, YoY

-154.91%

Forecast

P/E (FWD)

6.4

EPS (FWD)

1.402

Dividends

Dividend yield

3.44%

Annual payout

R$0.31

Payout

34.89%

Dividend growth streak

1 year

Div.rating

About the company

Ticker

BLAU3

ISIN

Country

Brazil

Sector (GICS)

Healthcare

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics products. Blau Farmacêutica S.A. was incorporated in 1987 and is headquartered in Cotia, Brazil.

Frequently asked questions

What sector does Blau Farmacêutica S.A (BLAU3) operate in?

Blau Farmacêutica S.A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Blau Farmacêutica S.A (BLAU3) current stock price?

As of the latest data, Blau Farmacêutica S.A stock price is R$8.98, with a previous close of R$9.30. Blau Farmacêutica S.A lost -R$0.32 in the last trading session, representing a -3.44% loss.

What is Blau Farmacêutica S.A (BLAU3) current market capitalization?

Blau Farmacêutica S.A market cap is approximately 2.07 billion.

What is Blau Farmacêutica S.A (BLAU3) Earnings Per Share (EPS)?

The trailing EPS is R$0.94, and the forward EPS is R$1.40.

What is Blau Farmacêutica S.A (BLAU3) Price-to-Earnings (P/E) ratio?

Blau Farmacêutica S.A current P/E ratio is 9.55, with a forward P/E of 6.4.

What is Blau Farmacêutica S.A (BLAU3) EBITDA?

Blau Farmacêutica S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 104.23 million.

Does Blau Farmacêutica S.A (BLAU3) pay dividends?

Yes. Blau Farmacêutica S.A pays quarterly dividends with an annualized yield of 3.44% and an estimated annual payout of R$0.31 per share.

How did Blau Farmacêutica S.A (BLAU3) perform in its most recent earnings report?

In the last report (March 31, 2026), Blau Farmacêutica S.A posted an EPS surprise of -29.17% and a revenue surprise of -0.49%.

What is Blau Farmacêutica S.A (BLAU3) beta (volatility) score?

Blau Farmacêutica S.A has a beta of 0.392, indicating lower volatility than the overall market.